Apr 30, 2014Novartis’ Zykadia Approved for Late-Stage Lung Cancer Sixth Breakthrough Drug to Gain Wide Approval Colorado U.S. Senator Michael Bennet welcomed the U.S. Food and Drug Administration’s (FDA) approval of another breakthrough drug – this time for a lung cancer drug manufactured by Novartis. The drug, known as Z...
Michael Bennet U.S. Senator for ColoradoMenu